Steven Frommeyer introduces the two teams of competing physicians participating in Cancer Network® Face-off.
Relapsed/Refractory Multiple Myeloma Trial Updates From ASCO 2023
August 7th 2023Experts from Mayo Clinic and The University of Texas MD Anderson Cancer Center discuss results from multiple myeloma trials presented at the 2023 American Society of Clinical Oncology Annual Meeting and how they may apply to clinical practice.
Real-world Teclistamab Use Finds Comparable Efficacy With MajesTec-1 in Multiple Myeloma
September 29th 2023When teclistamab was evaluated in a real-world setting, investigators determined that efficacy was similar between that and the phase 2 MajesTec-1 trial for patients with relapsed/refractory multiple myeloma.
2 Clarke Drive
Cranbury, NJ 08512